The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction
Clinical trial NCT03186456 · SUSPENDED
Trial details
- NCT number
- NCT03186456
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-31
- Primary completion
- 2027-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.